Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
Citalopram
Lundbeck ( Ireland ) Limited
N06AB; N06AB04
Citalopram
40 milligram(s)/millilitre
Oral drops, solution
Product subject to prescription which may not be renewed (A)
Selective serotonin reuptake inhibitors; citalopram
Marketed
1999-04-16
1 PACKAGE LEAFLET: INFORMATION FOR THE USER CIPRAMIL 40 MG/ML ORAL DROPS, SOLUTION Citalopram (as hydrochloride) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET 1. What Cipramil is and what it is used for 2. What you need to know before you take Cipramil 3. How to take Cipramil 4. Possible side effects 5. How to store Cipramil 6. Contents of the pack and other information 1. WHAT CIPRAMIL IS AND WHAT IT IS USED FOR HOW DOES CIPRAMIL WORK Cipramil belongs to a group of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs). These medicines act on the serotonin-system in the brain by increasing the serotonin level. WHAT IS CIPRAMIL USED FOR Cipramil contains citalopram and is used for the treatment of depression and when you feel better, to help prevent these symptoms recurring. Further, Cipramil is used for long-term treatment to prevent the occurrence of new depressive episodes in patients who have recurrent depression. Cipramil is also beneficial in relieving symptoms in patients prone to panic attacks. Ask your doctor if you have any questions about why Cipramil has been prescribed for you. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CIPRAMIL DO NOT TAKE CIPRAMIL: • if you are allergic to citalopram or any of the other ingredients of this medicine (listed in section 6). • if you take other medicines which belong to a group called monoamine oxidase inhibitors (MAOIs). MAOIs include medicines such as phenelzine, iproniazid, isocarboxazid, nialamide, tranylcypromine, selegiline (used in the treatmen Leggi il documento completo
Health Products Regulatory Authority 11 October 2023 CRN00DF18 Page 1 of 13 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cipramil 40 mg/ml Oral drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 40 mg citalopram (as 44.48 mg citalopram hydrochloride) 1 ml = 20 drops. 1 drop = 2 mg citalopram Excipients with known effect : Methyl parahydroxybenzoate (E218) 1.0 mg/ml Propyl parahydroxybenzoate (E216) 0.1 mg/ml Ethanol 96% 76.0 mg/ml For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral drops, solution. Clear, nearly colourless to yellowish solution with a bitter taste. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Depressive illness in the initial phase and as maintenance against potential relapse/recurrence. Cipramil is also indicated in the treatment of panic disorder with or without agoraphobia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Depression_ _Adults:_ Citalopram drops should be administered as a single oral dose of 16 mg (8 drops) daily. Depending on individual patient response, the dose may be increased to a maximum of 32 mg (16 drops) daily. _Duration of treatment:_ The antidepressant effect usually sets in after 2 to 4 weeks. Treatment with antidepressants is symptomatic and must therefore be continued for an appropriate length of time, usually up to 6 months after recovery in order to prevent relapse. In patients with recurrent depression (unipolar) maintenance therapy may need to be continued for a number of years to prevent new episodes. _Panic Disorder_ _Adults:_ A single oral dose of 8 mg (4 drops) daily is recommended for the first week before increasing the dose to 16 mg (8 drops) daily. Depending on individual patient response, the dose may be increased to a maximum of 32 mg (16 drops) daily. _Duration of treatment:_ Maximum effectiveness of citalopram in treating panic disorder is reached after about 3 months and the response is maintained during continued treatment. Health Products Regulatory Authority 11 Octobe Leggi il documento completo